Ozempic, Wegovy-maker hires lobbying firm to push for Medicare coverage
The blockbuster weight loss drugs' access to a key market — older Americans — is limited, as Medicare is banned from covering weight loss drugs as part of the Part D program.
The blockbuster weight loss drugs' access to a key market — older Americans — is limited, as Medicare is banned from covering weight loss drugs as part of the Part D program.
What's Your Reaction?
